Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204.SZ)

CNY 7.86

(0.51%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 1.33 Billion 1.66 Billion 1.82 Billion 1.85 Billion 1.86 Billion 2.77 Billion
Total Current Assets 238.88 Million 529.05 Million 688.44 Million 903.32 Million 1.02 Billion 1.55 Billion
Cash And Short Term Investments 85.18 Million 264.98 Million 466.46 Million 601.81 Million 627.61 Million 365.2 Million
Cash and Cash Equivalents 85.18 Million 264.98 Million 85.01 Million 140.57 Million 352.61 Million 365.2 Million
Short Term Investments - -219.66 Thousand 381.45 Million 461.24 Million 275 Million -1.27 Million
Net Receivables 68.02 Million 243.91 Million 196.18 Million 142.3 Million 175.19 Million 217.29 Million
Inventory 20.92 Million 18.82 Million 25 Million 38.09 Million 51.09 Million 43.33 Million
Other Current Assets 64.75 Million 1.33 Million 789.87 Thousand 121.1 Million 167.26 Million 926.97 Million
Total Non-Current Assets 1.09 Billion 1.14 Billion 1.13 Billion 952.88 Million 841.23 Million 1.21 Billion
Net PPE 262.34 Million 290.58 Million 312.42 Million 295.17 Million 317.17 Million 298.68 Million
Good Will And Intangible Assets 117.37 Million 126.97 Million 109.51 Million 125.27 Million 72.51 Million 64.45 Million
Good Will 19.75 Million 19.75 Million 22.17 Million 22.17 Million 22.17 Million 19.75 Million
Intangible Assets 97.61 Million 107.22 Million 87.33 Million 103.09 Million 50.33 Million 44.7 Million
Long-Term Investments 549.53 Million 522.47 Million 163.97 Million -17.21 Million 105.76 Million 793.88 Million
Tax Assets 163.99 Million 198.13 Million 155.84 Million 79.86 Million 42.72 Million 29.55 Million
Other Non Current Assets 82.54 Thousand 2.09 Million 396.78 Million 469.78 Million 303.05 Million 32.76 Million
Other Assets 0.00 - - - - -
Total Liabilities 282.31 Million 315.45 Million 276.24 Million 268.69 Million 227.18 Million 314.3 Million
Total Current Liabilities 208.17 Million 231.77 Million 196.63 Million 208.19 Million 178.37 Million 232.66 Million
Account Payables 72.9 Million 35.86 Million 31.7 Million 19.63 Million 12.47 Million 18.18 Million
Tax Payables 1.1 Million 7.12 Million 3.65 Million 2.23 Million 4.98 Million 1.69 Million
Short Term Debt 40.95 Million 2.68 Million 5.57 Million 51.2 Million 3.63 Million 3.51 Million
Deferred Revenue 2.85 Million 82.9 Million 43.11 Million 39.89 Million 42.34 Million 39.38 Million
Other Current Liabilities 91.45 Million 110.3 Million 116.24 Million 97.46 Million 119.9 Million 171.57 Million
Total Non Current Liabilities 74.14 Million 83.67 Million 79.6 Million 60.5 Million 48.81 Million 81.63 Million
Long-Term Debt - 3.17 Million 5.37 Million 7.8 Million 7.67 Million 11.31 Million
Deferred Revenue Non Current 29.23 Million 33.47 Million 21.32 Million 23.34 Million 23.6 Million 18.46 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities -29.23 Million 1.00 - -4.48 Million - 1.00
Other Liabilities - - - - 1.00 1.00
Total Equity 1.02 Billion 1.35 Billion 1.55 Billion 1.58 Billion 1.63 Billion 2.45 Billion
Stock Holders Equity 1.02 Billion 1.35 Billion 1.55 Billion 1.58 Billion 1.63 Billion 2.45 Billion
Common Stock 477.77 Million 475.35 Million 476.03 Million 476.03 Million 476.03 Million 476.7 Million
Retained Earnings -253.03 Million 145.2 Million 341.57 Million 478.59 Million 604.95 Million 896.78 Million
Accumulated other comprehensive income 341.41 Million 293.2 Million 325.43 Million 259.96 Million 181.33 Million 623.44 Million
Common Stock Equity 1.02 Billion 1.35 Billion 1.55 Billion 1.58 Billion 1.63 Billion 2.45 Billion
Capital Lease Obligation - 3.17 Million 5.37 Million 7.8 Million - -
Total Investments 549.53 Million 522.25 Million 545.42 Million 444.03 Million 380.77 Million 792.6 Million
Total Debt 40.95 Million 5.86 Million 10.94 Million 51.2 Million 3.63 Million 3.51 Million
Net Debt -44.22 Million -259.12 Million -74.06 Million -89.36 Million -348.97 Million -361.68 Million

Balance Sheet Charts